Company intelligence / Profile preview

Freese

Hamburg, Germany

Ownership: Private
Development stage: Other

Overview

Freese is a biotechnology company focused on the development of novel therapeutic solutions, primarily in the field of oncology. The company leverages its expertise in small molecule drug discovery to identify and optimize candidates for challenging biological targets. Freese aims to address significant unmet medical needs by advancing its internal pipeline through early-stage research and development. While currently in the pre-clinical phase, the company is actively building its portfolio and exploring strategic partnerships to accelerate its programs toward clinical evaluation.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Freese.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Freese.

Explore the full profile